Thus, emodin was found to suppress cancer cell-induced macrophage M2-like polarization, inhibit polarized macrophage-induced TGF-β1 production in breast cancer cells, and block EMT of breast cancer cells induced by TGF-β1 from both macrophages and cancer cells. Here, TGFB1 is linked to breast cancer.